Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for emergence sedation after laparoscopic cholecystectomy
RBR-7rtnwfrPhase 4Recruiting
- Sponsor
- Faculdade de Ciências Médicas de Pernambuco
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain, postoperative nausea and vomiting (PONV) and Emergence agitation (EA) (2 arms), sponsored by Faculdade de Ciências Médicas de Pernambuco. Primary endpoint: Agitation at awakening. Started Nov 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)Emergence agitation (EA)
Beyond the preview
Go deeper on RBR-7rtnwfr.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7rtnwfr.